Research helps the medical community better understand diseases and can lead to advances in diagnosis and treatments. The knowledge gained through your participation in the MOXIe clinical trial may ultimately benefit many patients by helping to identify safe and effective medicines for patients with FA.
The ethics and laws that govern medical practice also apply to clinical studies. A process called informed consent ensures you know all the facts regarding the study (including potential side effects), the investigational drug, and your condition. If you decide to participate, you will sign an informed consent document. This document is not binding and you may withdraw from the study at any time, for any reason.
If you choose to participate the study team, including the study doctor and his or her staff, will manage your study-related care throughout your participation. You will be encouraged to continue seeing your regular doctor for routine care.
Reata Pharmaceuticals, study sponsor, will provide the investigational drug, study-related procedures, and doctor visits will be provided at no cost. You may be compensated for your time and travel, including airline and lodging costs, if these are needed.